MedTrace Logo

A Phase 3 Clinical Trials for Bowel Preparation for Colonoscopy

NCT06287606 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 161

Last updated 2024-11-29

No results posted yet for this study

Summary

A prospective randomized study compared to the active control. Researchers compare colon cleansing in patients undergoing colonoscopy

Conditions

  • Bowel Preparation

Interventions

DRUG

CTP0302-A

Subjects randomized into group CTP0302-A will take a bowel preparation from the evening until the following morning.

DRUG

CTP0302-B

Subjects randomized into group CTP0302-B will take a bowel preparation on the Colonoscopy day

DRUG

Conventional OST

Subjects randomized into group Conventional OST will take a bowel preparation from the evening until the following morning.

Sponsors & Collaborators

  • Taejoon Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Jaemyung Cha, MD. PhD · Kyung Hee University Hospital at Gangdong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-29
Primary Completion
2024-01-04
Completion
2024-01-04

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06287606 on ClinicalTrials.gov